HISTORY
Based in Montreal, Neurenati Therapeutics is a pioneering biotechnology company focusing on the development of therapies for rare diseases. It was founded in 2020 by two academic researchers, Dr. Nicolas Pilon, a rare diseases and neural crest cell development expert, and Dr. Rodolphe Soret, a neuro-gastroenterology specialist. Dr. Pilon and Dr. Soret combined their expertise to develop an innovative treatment for Hirschsprung disease. With Dr. Maxime Ranger, a serial entrepreneur with extensive experience in drug development and biotechnology company startup, and supported by several experts in preclinical and clinical development, the Neurenati team is currently focusing its efforts on advancing its therapy for Hirschsprung disease.
MISSION
Our mission is to develop breakthrough therapies for rare pediatric diseases, starting with Hirschsprung disease.
Combining innovative approaches with a deep commitment to patients, we aim to transform how these conditions are treated, moving beyond symptom management and toward curative solutions for children affected by rare diseases worldwide.
VISION
Our vision is to redefine the treatment of rare pediatric diseases.
Neurenati aims at becoming a global leader in regenerative and disease-modifying therapies that not only improve disease outcome, but ultimately cure children with rare diseases, hence giving every child the chance to live a healthy life.
VALUES
Global Caring
Children and families are at the heart of everything we do.
Rare diseases affect communities around the world and we are committed to developing therapies that bring transformative and meaningful changes to patients lives. Our work is guided by scientific rigor, ethical responsibility, commitment to global access, integrity, and respect for children and their families.
Passion & Boldness
We believe transformative therapies require heart and boldness.
Our team challenges scientific boundaries, embraces complex problems, and pursues breakthrough discoveries with scientific excellence, curiosity, courage and determination. Innovation is not optional, it is our responsibility to patients. Our passion fuels our purpose, our boldness turns possibility into life-changing impact.
Unity & Openness
Great science happens together.
We foster a culture of openness, respect, mutual trust, humility and cooperation across disciplines, institutions, and borders. By collaborating with researchers, clinicians, partners, and patient communities and valuing diverse perspectives, we accelerate the development of therapies that matter. By working together, we strengthen our collective expertise and accelerate solutions that truly serve children in need.
